Vice President Patents at CureVac AG - Boston, MA, US
Chief Scientific Officer
Contact Igor Splawski
Senior Scientist Clinical Immunomonitoring
Contact Sandra Lazzaro
Group Manager GMP Service Provider
Contact Julia Walz
Senior Group Manager
Contact Thomas Pruss
SVP Manufacturing and Supply Chain, Managing Director
Contact Barbara Philippe
Executive Medical Director, Oncology
Contact Martin Falk
Scientist, Product Design and Formulation
Contact Paula Muresan
CureVac is a biopharmaceutical company that develops and commercializes mRNA-based therapies for the treatment of cancer and infectious diseases.